Search All News
We talked with Dr. Harding to learn more about her book, "The Rabbit Effect," and about the hidden factors that make us healthy.
Opening remarks were delivered by Dr. Blair Simpson, interim chair of psychiatry at Columbia.
A Columbia study, which enrolls children ages 4-6 in a camp-like setting, seeks to learn which play activities best soothe anxious children.
Data from Columbia Mass Murder Database reveal psychosis and other serious psychiatric illness absent in the majority of perpetrators.
Source:MedscapeFebruary 20, 2020
The study "contributes to efforts that may one day redefine the diagnostic system in psychiatry, which may have practical clinical implications," commented Dr. Tiffany Herlands.
- January 22, 2020
Researchers at Columbia University found that non-medical cannabis use—including frequent or problematic use—is significantly more common in adults with pain than in those without pain.
- January 21, 2020
National statistics on medication treatment for opioid addiction show that buprenorphrine use is increasing in all age groups except the young.
Source:New York TimesJanuary 14, 2020
Dr. Mark Olfson said looking at large groups, instead of homing in on specific individuals, allows for other factors to affect the suicide rates — even if the study tried to control for some of them.
- January 13, 2020
Researchers at Columbia University used magnetic resonance imaging (MRI) to understand brain structural alterations in children and adolescents with OCD that predict psychotherapy treatment response.
- January 10, 2020
A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons suggests that prenatal exposure to flame retardants may increase the risk of reading problems.
Source:MedscapeJanuary 9, 2020
"We were surprised to learn that there has been a larger decrease in opioid prescribing to adults with more rather than less severe pain," Dr. Mark Olfson said.
Source:MD MagazineJanuary 8, 2020
In an accompanying editorial, Dr. Joshua T. Kantrowitz explained how the future role of lumateperone could be crucial in treating schizophrenia patients.
- January 6, 2020
The Center for OCD and Related Disorders, directed by Dr. Blair Simpson, focuses on how to better understand, and ultimately treat, obsessive-compulsive disorder and related problems.
Source:MD MagazineDecember 23, 2019
“The efficacy and safety profile of CAPLYTA approved by the FDA, offers healthcare providers an important new option for treating people living with schizophrenia,” said Dr. Jeffrey A. Lieberman.